Back to Journals » Cancer Management and Research » Volume 13

Review

Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors

       
Total article views   HTML views PDF downloads Totals
3,835 Dovepress* 3,556+ 217 3,773
PubMed Central* 279 92 371
Totals 3,835 309 4,144
*Since 4 October 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar